Simon Gaskell

Last updated

Simon Gaskell
Born
Simon J. Gaskell

(1950-05-02) 2 May 1950 (age 74)
NationalityBritish
Alma mater University of Bristol
Scientific career
Institutions Queen Mary University of London

Simon James Gaskell (born 2 May 1950) [1] is the previous president and principal of Queen Mary University of London, and current chair of the Quality Assurance Agency for Higher Education [2] [3] and chair of the board of governors of the University of Plymouth. He previously served as the vice-president for research at the University of Manchester. [3]

Contents

Early life and career

He was born in 1950 and educated at Haberdashers' Aske's Boys' School and the University of Bristol, where he gained a BSc and PhD in chemistry. [3]

Gaskell's career has spanned a number of leading academic and management posts in the UK and the United States. Following a bachelor's degree and a PhD at the University of Bristol, he took up his first research post in 1974 at the University of Glasgow. He then became head of the Mass Spectrometry Unit at the University of Wales College of Medicine, during which period he spent a sabbatical year at the National Institute of Environmental Health Sciences in North Carolina, USA. He returned to the USA in 1987 to become Professor of Experimental Medicine in the Baylor College of Medicine, Houston and Adjunct Professor of Pharmacology and Chemistry at the University of Houston from 1989.

He joined UMIST as Professor of Mass Spectrometry in 1993, before becoming Head of Chemistry in 1999 and, following the merger of the two institutions (with which he was closely involved), Associate Vice President for Research in the University of Manchester in 2004, and Vice President for Research in 2006. He joined Queen Mary University of London as Principal in October 2009.

Gaskell also served as chair of the board of the Higher Education Statistics Agency (HESA) from 2013 to 2017, and as Treasurer for Universities UK, the representative organisation for UK universities, from 1 August 2012. Since 14 March 2019, he has been chair of the board of the Quality Assurance Agency for Higher Education. [2]

He has been a member of the board of governors of the University of Plymouth since 2019, and its chair since 2022.

Research interests

A Fellow of the Royal Society of Chemistry, Simon Gaskell sits on a number of advisory boards and panels, and is also on the editorial board of a range of academic journals.[ citation needed ]

He conducted research at the Michael Barber Centre for Mass Spectrometry at the University of Manchester. His work there involved the development and application of state-of-the-art mass spectrometry, with particular applications in the biomedical sciences.

In recent years, international efforts have been made to sequence the genomes of many organisms, including man. These studies of an organism's entire DNA sequence (known as genomics) have in turn led to the development of a similar field of research, called 'proteomics'. Proteomics is the study of the structure and function of a cell's entire set of proteins, which orchestrate the chemical reactions that occur within cells. To understand how a cell works, scientists need to know which proteins are present and in what amounts. Gaskell's research uses various forms of an analytical technique called mass spectrometry to determine the quantity and longevity of these different proteins. Gaskell has recently used these techniques to study a human parasite called Trypanosoma Brucei . It causes sleeping sickness, which affects around 400,000 people each year, predominantly in the developing world.[ citation needed ]

Controversy

One of Queen Mary University of London's strategic aims was to build upon the institution's global research impact as measured by, among other things, ranking in league tables.

In 2012, during a reorganisation in The School of Biological and Chemical Sciences, staff members were dismissed on grounds of redundancy while similar posts were advertised. The grounds for dismissal were based on income from research grants, on a count of the number of papers published, and on the impact factor of the journal in which the papers appeared. These criteria are widely regarded as being poor indicators of the worth of individual scientists. [4] Articles and letters in The Times, [5] and in Times Higher Education, [6] and on blogs discussed the claims. [7] Queen Mary has responded to these criticisms with a Frequently Asked Questions document [8] and a comment piece by Simon Gaskell in Times Higher Education. [9]

Affiliations

He has been a member of the board of governors of the University of Plymouth since 2019, and its chair since 2022. [10]

Selected bibliography

Books

Journals

Related Research Articles

<span class="mw-page-title-main">Proteomics</span> Large-scale study of proteins

Proteomics is the large-scale study of proteins. Proteins are vital parts of living organisms, with many functions such as the formation of structural fibers of muscle tissue, enzymatic digestion of food, or synthesis and replication of DNA. In addition, other kinds of proteins include antibodies that protect an organism from infection, and hormones that send important signals throughout the body.

<span class="mw-page-title-main">Tandem mass spectrometry</span> Type of mass spectrometry

Tandem mass spectrometry, also known as MS/MS or MS2, is a technique in instrumental analysis where two or more stages of analysis using one or more mass analyzer are performed with an additional reaction step in between these analyses to increase their abilities to analyse chemical samples. A common use of tandem MS is the analysis of biomolecules, such as proteins and peptides.

<span class="mw-page-title-main">Max Planck Institute of Biochemistry</span> Research institute in Martinsried, Germany

The Max Planck Institute of Biochemistry is a research institute of the Max Planck Society located in Martinsried, a suburb of Munich. The institute was founded in 1973 by the merger of three formerly independent institutes: the Max Planck Institute of Biochemistry, the Max Planck Institute of Protein and Leather Research, and the Max Planck Institute of Cell Chemistry.

<span class="mw-page-title-main">Ruedi Aebersold</span> Swiss biologist (born 1954)

Rudolf Aebersold is a Swiss biologist, regarded as a pioneer in the fields of proteomics and systems biology. He has primarily researched techniques for measuring proteins in complex samples, in many cases via mass spectrometry. Ruedi Aebersold is a professor of Systems biology at the Institute of Molecular Systems Biology (IMSB) in ETH Zurich. He was one of the founders of the Institute for Systems Biology in Seattle, Washington, United States where he previously had a research group.

<span class="mw-page-title-main">Matthias Mann</span> German physicist and biochemist (born 1959)

Matthias Mann is a German physicist and biochemist. He is doing research in the area of mass spectrometry and proteomics.

Donald F. Hunt is the University Professor of Chemistry and Pathology at the University of Virginia. He is known for his research in the field of mass spectrometry, he developed electron capture negative ion mass spectrometry. He has received multiple awards for his work including the Distinguished Contribution Award from the American Society for Mass Spectrometry and the Thomson Medal from the International Mass Spectrometry Society.

Shotgun proteomics refers to the use of bottom-up proteomics techniques in identifying proteins in complex mixtures using a combination of high performance liquid chromatography combined with mass spectrometry. The name is derived from shotgun sequencing of DNA which is itself named after the rapidly expanding, quasi-random firing pattern of a shotgun. The most common method of shotgun proteomics starts with the proteins in the mixture being digested and the resulting peptides are separated by liquid chromatography. Tandem mass spectrometry is then used to identify the peptides.

Joshua Coon is a professor of chemistry and biomolecular chemistry and the inaugural holder of the Thomas and Margaret Pyle Chair at the University of Wisconsin–Madison, and an affiliate of the Morgridge Institute for Research.

<span class="mw-page-title-main">Albert J. R. Heck</span> Dutch chemist

Albert J.R. Heck is a Dutch scientist and professor at Utrecht University, the Netherlands in the field of mass spectrometry and proteomics. He is known for his work on technologies to study proteins in their natural environment, with the aim to understand their biological function. Albert Heck was awarded the Spinoza Prize in 2017, the highest scientific award in the Netherlands.

Richard Dale Smith is a chemist and a Battelle Fellow and chief scientist within the biological sciences division, as well as the director of proteomics research at the Pacific Northwest National Laboratory (PNNL). Smith is also director of the NIH Proteomics Research Resource for Integrative Biology, an adjunct faculty member in the chemistry departments at Washington State University and the University of Utah, and an affiliate faculty member at the University of Idaho and the Department of Molecular Microbiology & Immunology, Oregon Health & Science University. He is the author or co-author of approximately 1100 peer-reviewed publications and has been awarded 70 US patents.

<span class="mw-page-title-main">Margaret Sheil</span> Australian academic

Margaret Mary Sheil is an Australian academic and the Vice Chancellor of Queensland University of Technology.

Renã A. S. Robinson is an associate professor and the Dorothy J. Wingfield Phillips Chancellor's Faculty Fellow in the department of chemistry at the Vanderbilt University, where she is the principal investigator of the RASR Laboratory.

<span class="mw-page-title-main">Gerry McKenna</span> Northern Irish politician (born 1953)

Patrick Gerald McKenna, DL, FIBMS, FRSB, MRIA, known informally and widely as Gerry McKenna, is a Chartered Biologist and Chartered Scientist from Northern Ireland.

Milan Mrksich is an American chemist. He is the Henry Wade Rogers Professor at Northwestern University with appointments in chemistry, biomedical engineering and cell & developmental biology. He also serves as both the founding director of the center for Synthetic Biology and as an associate director of the Robert H. Lurie Comprehensive Cancer Center at Northwestern. Mrksich also serves as the Vice President for Research of Northwestern University.

<span class="mw-page-title-main">Claire E. Eyers</span> British biological mass spectrometrist

Claire Eyers is a British biological mass spectrometrist who is professor of biological mass spectrometry at the University of Liverpool, where she heads up the Centre for Proteome Research. Her research publications list her either as Claire E Haydon or Claire E Eyers.

Ying Ge is a Chinese-American chemist who is a Professor of Cell and Regenerative Biology at the University of Wisconsin–Madison. Her research considers the molecular mechanisms that underpin cardiac disease. She has previously served on the board of directors of the American Society for Mass Spectrometry. In 2020 Ge was named on the Analytical Scientist Power List.

Jennifer Eileen Van Eyk is the Erika Glazer Chair in Women's Heart Health, the Director of Advanced Clinical Biosystems Institute in the Department of Biomedical Sciences, the Director of Basic Science Research in the Women's Heart Center, a Professor in Medicine and in Biomedical Sciences at Cedars-Sinai. She is a renowned scientist in the field of clinical proteomics.

Juri Rappsilber is a German chemist in the area of mass spectrometry and proteomics.

Lingjun Li is a Professor in the School of Pharmacy and Department of Chemistry at University of Wisconsin-Madison. She develops mass spectrometry based tools to study neuropeptides, peptide hormones and neurotransmitters.

Helen Jill Cooper is a British chemist who is Professor of mass spectrometry at the University of Birmingham. She serves as Deputy Head of the School of Chemistry and holds an Engineering and Physical Sciences Research Council Established Career Fellowship. Her research considers the development of native ambient mass spectrometry to enable direct analysis of intact proteins and protein assemblies from tissue.

References

Academic offices
Preceded by
Professor Philip Ogden (Acting Principal)
Principal of Queen Mary University of London
2009 – Present
Succeeded by
Incumbent